Physician profile
Jared A Davis
NPI 1922234699
$45,429.74
in general payments reported to CMS, 2019-2025
24 companies · $4,044 in 2025
The $4,044 reported for 2025 was more than what 91% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,718 · 2020: $14K · 2021: $12K · 2022: $8,076 · 2023: $730 · 2024: $997 · 2025: $4,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,271 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,270.93 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22,326.05 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Accurian |
| Medtronic USA, INC. | $18,258.19 | 2019-2020 | |
| Boston Scientific Corporation | $1,226.48 | 2019-2025 | Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Rivanna Medical, INC | $900.00 | 2022 | |
| Abbott Laboratories | $663.57 | 2019-2025 | Proclaim, Eterna |
| Spr Therapeutics, INC | $511.98 | 2020-2025 | Sprint Pns System |
| Abbvie INC. | $306.59 | 2021-2025 | Ubrelvy |
| Relievant Medsystems, INC. | $238.15 | 2022-2023 | Intracept |
| Tersera Therapeutics LLC | $189.67 | 2019-2025 | Prialt |
| Bioventus LLC | $162.54 | 2019-2024 | Durolane, Durolane |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $160.09 | 2022-2025 | Relistor |
| Biohaven Pharmaceutical Holding Company LTD. | $127.25 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $96.64 | 2024-2025 | |
| Pfizer INC. | $38.68 | 2019-2023 | |
| Avanos Medical | $33.31 | 2022-2023 | Coolief* Cooled Radiofrequency |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $33.08 | 2020 | |
| Fidia Pharma USA INC. | $23.65 | 2020 | |
| Kaleo, INC. | $22.96 | 2019 | |
| Nevro Corp. | $21.95 | 2024 | Senza |
| Novo Nordisk INC | $20.26 | 2019 | |
| Kyowa Kirin, INC. | $18.52 | 2024 | Crysvita |
| Ferring Pharmaceuticals INC. | $18.07 | 2019 | |
| Hikma Pharmaceuticals USA | $16.91 | 2022 | |
| Vertos Medical, INC. | $15.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.